4.7 Article

GSAP regulates lipid homeostasis and mitochondrial function associated with Alzheimer's disease

期刊

JOURNAL OF EXPERIMENTAL MEDICINE
卷 218, 期 8, 页码 -

出版社

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20202446

关键词

-

资金

  1. Memorial Sloan Kettering Cancer Center Support Grant/Core Grant [P30 CA008748]
  2. Memorial Sloan Kettering Molecular Cytology Core Facility/Core Grant [P30 CA 008748]
  3. Fisher Center for Alzheimer's Research Foundation
  4. National Institute on Aging [AG061350]
  5. JPB Foundation
  6. National Institutes of Health [AG047270, AG062306, AG066508, DA018343]
  7. State of Connecticut Department of Mental Health and Addiction Services
  8. National Key R&D Program of China [2018YFE0203600]
  9. Guangdong Provincial Key ST Program [2018B030336001]
  10. Hong Kong Research Grants Council Theme-based Research Scheme [T13-605/18-W]
  11. Area of Excellence Scheme of the University Grants Committee [AoE/M-604/16]
  12. National Institutes of Health

向作者/读者索取更多资源

Research has shown that GSAP plays important roles in Alzheimer's disease and Down's syndrome by regulating multiple biological pathways including protein phosphorylation, trafficking, lipid metabolism, and mitochondrial function. GSAP physically interacts with the Fe65-APP complex to regulate APP trafficking/partitioning, is enriched in the mitochondria-associated membrane, and affects lipid homeostasis through the amyloidogenic processing of APP. Deletion of GSAP can lead to an unfavorable lipid environment for AD pathogenesis, improved mitochondrial function, and rescue of cognitive deficits in an AD mouse model.
Biochemical, pathogenic, and human genetic data confirm that GSAP (gamma-secretase activating protein), a selective gamma-secretase modulatory protein, plays important roles in Alzheimer's disease (AD) and Down's syndrome. However, the molecular mechanism(s) underlying GSAP-dependent pathogenesis remains largely elusive. Here, through unbiased proteomics and single-nuclei RNAseq, we identified that GSAP regulates multiple biological pathways, including protein phosphorylation, trafficking, lipid metabolism, and mitochondrial function. We demonstrated that GSAP physically interacts with the Fe65-APP complex to regulate APP trafficking/partitioning. GSAP is enriched in the mitochondria-associated membrane (MAM) and regulates lipid homeostasis through the amyloidogenic processing of APP. GSAP deletion generates a lipid environment unfavorable for AD pathogenesis, leading to improved mitochondrial function and the rescue of cognitive deficits in an AD mouse model. Finally, we identified a novel GSAP single-nucleotide polymorphism that regulates its brain transcript level and is associated with an increased AD risk. Together, our findings indicate that GSAP impairs mitochondrial function through its MAM localization and that lowering GSAP expression reduces pathological effects associated with AD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据